Basic Information
RNALocate ID: RLID:11001359
RNA Symbol: hsa-miR-139-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-139-5p
RNA ID: miRBase:MIMAT0000250
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001594 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11001358 Exosome Plasma 29323722
RLID:11001360 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000044 Exosome Blood
RLID-D:11000313 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-139-5p Diffuse large b cell lymphoma MNDR-E-MI-13088
MNDR hsa-miR-139-5p Splenic marginal zone lymphoma MNDR-E-MI-13089
MNDR hsa-miR-139-5p Multiple sclerosis chronic progressive MNDR-E-MI-13090
MNDR hsa-miR-139-5p Oral squamous cell carcinoma MNDR-E-MI-13091
MNDR hsa-miR-139-5p Large cell neuroendocrine cancer MNDR-E-MI-13092
MNDR hsa-miR-139-5p Follicular lymphoma MNDR-E-MI-13093
MNDR hsa-miR-139-5p Medulloblastoma MNDR-E-MI-13094
MNDR hsa-miR-139-5p Uterine corpus endometrial carcinoma MNDR-E-MI-13095
MNDR hsa-miR-139-5p Lymphoma MNDR-E-MI-13096
MNDR hsa-miR-139-5p Lymphoma non-hodgkin MNDR-E-MI-13097
MNDR hsa-miR-139-5p Estrogen-receptor positive breast cancer MNDR-E-MI-13098
MNDR hsa-miR-139-5p Estrogen-receptor negative breast cancer MNDR-E-MI-13099
MNDR hsa-miR-139-5p Progesterone-receptor positive breast cancer MNDR-E-MI-13100
MNDR hsa-miR-139-5p Progesterone-receptor negative breast cancer MNDR-E-MI-13101
MNDR hsa-miR-139-5p Her2-receptor positive breast cancer MNDR-E-MI-13102
MNDR hsa-miR-139-5p Breast cancer luminal MNDR-E-MI-13103
MNDR hsa-miR-139-5p Prostate cancer MNDR-E-MI-13104
MNDR hsa-miR-139-5p Gastric cancer MNDR-E-MI-13105
MNDR hsa-miR-139-5p Gastric lymphoma MNDR-E-MI-13106
MNDR hsa-miR-139-5p Alzheimer disease MNDR-E-MI-13107
MNDR hsa-miR-139-5p Intracranial aneurysm MNDR-E-MI-13108
MNDR hsa-miR-139-5p Bladder cancer MNDR-E-MI-13109
MNDR hsa-miR-139-5p Esophageal carcinoma MNDR-E-MI-13110
MNDR hsa-miR-139-5p Dysautonomia familial MNDR-E-MI-13111
MNDR hsa-miR-139-5p Head and neck cancer MNDR-E-MI-13112
MNDR hsa-miR-139-5p Primary biliary cirrhosis MNDR-E-MI-13113
MNDR hsa-miR-139-5p Huntington disease MNDR-E-MI-13114
MNDR hsa-miR-139-5p Chorea MNDR-E-MI-13115
MNDR hsa-miR-139-5p Cardiovascular disease MNDR-E-MI-13116
MNDR hsa-miR-139-5p Carotid stenosis MNDR-E-MI-13117
MNDR hsa-miR-139-5p Uterine fibroid MNDR-E-MI-13118
MNDR hsa-miR-139-5p Lung cancer MNDR-E-MI-13119
MNDR hsa-miR-139-5p Endometrial cancer MNDR-E-MI-13120
MNDR hsa-miR-139-5p Down syndrome MNDR-E-MI-13121
MNDR hsa-miR-139-5p Parkinson disease MNDR-E-MI-13122
MNDR hsa-miR-139-5p Basal-like breast cancer MNDR-E-MI-13123
MNDR hsa-miR-139-5p Neuroendocrine neoplasia MNDR-E-MI-13124
MNDR hsa-miR-139-5p Pituitary neoplasms MNDR-E-MI-13125
MNDR hsa-miR-139-5p Pancreatic cancer MNDR-E-MI-13126
MNDR hsa-miR-139-5p Melanoma MNDR-E-MI-13127
MNDR hsa-miR-139-5p Rectum adenocarcinoma MNDR-E-MI-13128
MNDR hsa-miR-139-5p Nephroblastoma MNDR-E-MI-13129
MNDR hsa-miR-139-5p Colon cancer MNDR-E-MI-13130
MNDR hsa-miR-139-5p Colon adenocarcinoma MNDR-E-MI-13131
MNDR hsa-miR-139-5p Familial ovarian cancer MNDR-E-MI-13132
MNDR hsa-miR-139-5p Basal cell carcinoma MNDR-E-MI-13133
MNDR hsa-miR-139-5p Prostate adenocarcinoma MNDR-E-MI-13134
MNDR hsa-miR-139-5p Carcinoma ductal breast MNDR-E-MI-13135
MNDR hsa-miR-139-5p Glioblastoma MNDR-E-MI-13136
MNDR hsa-miR-139-5p Astrocytoma MNDR-E-MI-13137
MNDR hsa-miR-139-5p Glioma MNDR-E-MI-13138
MNDR hsa-miR-139-5p Oligodendroglioma MNDR-E-MI-13139
MNDR hsa-miR-139-5p Amyotrophic lateral sclerosis MNDR-E-MI-13140
MNDR hsa-miR-139-5p Osteosarcoma MNDR-E-MI-13141
MNDR hsa-miR-139-5p Breast carcinoma MNDR-E-MI-13142
MNDR hsa-miR-139-5p Middle cerebral artery infarction MNDR-E-MI-13143
MNDR hsa-miR-139-5p Uterine cancer MNDR-E-MI-13144
MNDR hsa-miR-139-5p Gastric adenocarcinoma MNDR-E-MI-13145
MNDR hsa-miR-139-5p Cervical squamous cell carcinoma MNDR-E-MI-13146
MNDR hsa-miR-139-5p Pituitary adenoma MNDR-E-MI-13147
MNDR hsa-miR-139-5p Lung squamous cell carcinoma MNDR-E-MI-13148
MNDR hsa-miR-139-5p Carcinoma lung non-small-cell MNDR-E-MI-13149
MNDR hsa-miR-139-5p Lung adenocarcinoma MNDR-E-MI-13150
MNDR hsa-miR-139-5p Adrenocortical carcinoma MNDR-E-MI-13151
MNDR hsa-miR-139-5p Adrenal cortical carcinoma MNDR-E-MI-13152
MNDR hsa-miR-139-5p Thyroid carcinoma MNDR-E-MI-13153
MNDR hsa-miR-139-5p Bladder urothelial carcinoma MNDR-E-MI-13154
MNDR hsa-miR-139-5p Pancreatic adenocarcinoma MNDR-E-MI-13155
MNDR hsa-miR-139-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-13156
MNDR hsa-miR-139-5p Kidney renal clear cell carcinoma MNDR-E-MI-13157
MNDR hsa-miR-139-5p Kidney renal papillary cell carcinoma MNDR-E-MI-13158
MNDR hsa-miR-139-5p Clear cell renal cell carcinoma MNDR-E-MI-13159
MNDR hsa-miR-139-5p Allergic rhinitis MNDR-E-MI-13160
MNDR hsa-miR-139-5p Large cell carcinoma MNDR-E-MI-13161
MNDR hsa-miR-139-5p Cholangiocarcinoma MNDR-E-MI-13162
MNDR hsa-miR-139-5p Gallbladder carcinoma MNDR-E-MI-13163
MNDR hsa-miR-139-5p Esophageal cancer MNDR-E-MI-13164
MNDR hsa-miR-139-5p Liver cirrhosis MNDR-E-MI-13165
MNDR hsa-miR-139-5p Lung small cell carcinoma MNDR-E-MI-13166
MNDR hsa-miR-139-5p Head and neck squamous cell carcinoma MNDR-E-MI-13167
MNDR hsa-miR-139-5p Breast invasive carcinoma MNDR-E-MI-13168
MNDR hsa-miR-139-5p Early hepatocellular carcinoma MNDR-E-MI-13169
MNDR hsa-miR-139-5p Familiar ovarian carcinoma MNDR-E-MI-13170
MNDR hsa-miR-139-5p B-cell lymphoma MNDR-E-MI-13171
MNDR hsa-miR-139-5p Rheumatoid arthritis MNDR-E-MI-13172
MNDR hsa-miR-139-5p T-cell leukemia MNDR-E-MI-13173
MNDR hsa-miR-139-5p Malignant pleural mesothelioma MNDR-E-MI-13174
MNDR hsa-miR-139-5p Barrett's adenocarcinoma MNDR-E-MI-13175
MNDR hsa-miR-139-5p Chronic myeloid leukemia MNDR-E-MI-13176
MNDR hsa-miR-139-5p Hodgkin lymphoma MNDR-E-MI-13177
MNDR hsa-miR-139-5p Burkitt lymphoma MNDR-E-MI-13178
MNDR hsa-miR-139-5p Neuromyelitis optica MNDR-E-MI-13179
MNDR hsa-miR-139-5p Skin cutaneous melanoma MNDR-E-MI-13180
MNDR hsa-miR-139-5p Skin melanoma MNDR-E-MI-13181
MNDR hsa-miR-139-5p Acute myelogenous leukemia MNDR-E-MI-13182
MNDR hsa-miR-139-5p Colorectal cancer MNDR-E-MI-13183
MNDR hsa-miR-139-5p Nasopharyngeal carcinoma MNDR-E-MI-13184
MNDR hsa-miR-139-5p Ependymoma MNDR-E-MI-13185
MNDR hsa-miR-139-5p Cardiomegaly MNDR-E-MI-13186
MNDR hsa-miR-139-5p Prostatic neoplasms MNDR-E-MI-13187
MNDR hsa-miR-139-5p Sleep deprivation MNDR-E-MI-13188
MNDR hsa-miR-139-5p Cerebral hemorrhage traumatic MNDR-E-MI-13189
MNDR hsa-miR-139-5p Barrett's carcinogenesis MNDR-E-MI-13190
MNDR hsa-miR-139-5p Breast cancer her3+ negative MNDR-E-MI-13191
MNDR hsa-miR-139-5p Cardiac fibrosis MNDR-E-MI-13192
MNDR hsa-miR-139-5p Duke A MNDR-E-MI-13193
MNDR hsa-miR-139-5p Low grade dysplastic nodule MNDR-E-MI-13194
MNDR hsa-miR-139-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-13195
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACTC1 Homo sapiens RR00037075
TOP